GENFF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
4.52M
HRGN
Price
$1.70
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
27.06M
47 days until earnings call
Interact to see
Advertisement

GENFF vs HRGN

Header iconGENFF vs HRGN Comparison
Open Charts GENFF vs HRGNBanner chart's image
Genflow Biosciences
Price$0.01
Change-$0.00 (-0.00%)
Volume$70K
Capitalization4.52M
Harvard Apparatus Regenerative Technology
Price$1.70
Change-$0.00 (-0.00%)
Volume$1.01K
Capitalization27.06M
GENFF vs HRGN Comparison Chart in %
Loading...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GENFF vs. HRGN commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GENFF is a Hold and HRGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (GENFF: $0.01 vs. HRGN: $1.70)
Brand notoriety: GENFF and HRGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GENFF: 955% vs. HRGN: 20%
Market capitalization -- GENFF: $4.52M vs. HRGN: $27.06M
GENFF [@Biotechnology] is valued at $4.52M. HRGN’s [@Biotechnology] market capitalization is $27.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GENFF’s FA Score shows that 0 FA rating(s) are green whileHRGN’s FA Score has 0 green FA rating(s).

  • GENFF’s FA Score: 0 green, 5 red.
  • HRGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both GENFF and HRGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GENFF’s TA Score shows that 2 TA indicator(s) are bullish while HRGN’s TA Score has 4 bullish TA indicator(s).

  • GENFF’s TA Score: 2 bullish, 4 bearish.
  • HRGN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, HRGN is a better buy in the short-term than GENFF.

Price Growth

GENFF (@Biotechnology) experienced а -1.75% price change this week, while HRGN (@Biotechnology) price change was +6.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

HRGN is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRGN($27.1M) has a higher market cap than GENFF($4.52M). HRGN YTD gains are higher at: -42.953 vs. GENFF (-81.426).
GENFFHRGNGENFF / HRGN
Capitalization4.52M27.1M17%
EBITDAN/A-7.17M-
Gain YTD-81.426-42.953190%
P/E RatioN/AN/A-
RevenueN/A418K-
Total CashN/A1.73M-
Total DebtN/A272K-
FUNDAMENTALS RATINGS
HRGN: Fundamental Ratings
HRGN
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GENFFHRGN
RSI
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
33%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
33%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JFROF11.10N/A
N/A
J. Front Retailing Co., Ltd.
TSGTY30.60N/A
N/A
Tsingtao Brewery Co., Ltd.
MKKOF12.96N/A
N/A
Marimekko Oyj
THSGF0.78-0.01
-1.84%
THESIS GOLD INC.
OODH0.28-0.03
-9.68%
Orion Diversified Holding Co Inc.

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and TOVX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and TOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
TOVX - GENFF
25%
Poorly correlated
-1.56%
VRCA - GENFF
23%
Poorly correlated
+9.01%
SGMT - GENFF
10%
Poorly correlated
+1.73%
OCS - GENFF
6%
Poorly correlated
-0.81%
APGE - GENFF
3%
Poorly correlated
+7.08%
More

HRGN and

Correlation & Price change

A.I.dvisor tells us that HRGN and FTRE have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HRGN and FTRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRGN
1D Price
Change %
HRGN100%
N/A
FTRE - HRGN
6%
Poorly correlated
+0.97%
APLM - HRGN
3%
Poorly correlated
-6.40%
GENFF - HRGN
2%
Poorly correlated
N/A
ANL - HRGN
2%
Poorly correlated
-1.09%
CLDI - HRGN
2%
Poorly correlated
+5.09%
More